{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:26:23Z","timestamp":1792074383056,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","award":["2022KY661"],"award-info":[{"award-number":["2022KY661"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.acra.2026.06.010","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:37:51Z","timestamp":1782992271000},"page":"3824-3837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer using a Longitudinal US-based Stack-model"],"prefix":"10.1016","volume":"33","author":[{"given":"Tian","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirui","family":"Chuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0583-240X","authenticated-orcid":false,"given":"Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2026.06.010_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.acra.2026.06.010_bib2","first-page":"1216","article-title":"Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein","year":"2021","journal-title":"Ann\u00a0Oncol\u00a0Off\u00a0J\u00a0European Soc\u00a0Med\u00a0Oncol"},{"key":"10.1016\/j.acra.2026.06.010_bib3","article-title":"MRI radiomics for assessment of molecular subtype, pathological complete response, and residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy","author":"Choudhery","year":"2022","journal-title":"Acad\u00a0Radiol"},{"key":"10.1016\/j.acra.2026.06.010_bib4","first-page":"229","article-title":"Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival","volume":"32","author":"Magbanua","year":"2021","journal-title":"Ann\u00a0Oncol Off\u00a0J\u00a0European Society for Medical Oncology"},{"key":"10.1016\/j.acra.2026.06.010_bib5","first-page":"691","article-title":"Breast Cancer, Version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Gradishar","year":"2022","journal-title":"J\u00a0Nat\u00a0Compreh\u00a0Cancer Net\u00a0JNCCN"},{"key":"10.1016\/j.acra.2026.06.010_bib6","first-page":"591","article-title":"The clinical significance of breast-only and node-only pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT): a review of 20,000 breast cancer patients in the national cancer data base (NCDB)","volume":"268","author":"Fayanju","year":"2018","journal-title":"Ann\u00a0Surg"},{"key":"10.1016\/j.acra.2026.06.010_bib7","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/s41416-023-02403-x","article-title":"Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases","volume":"129","author":"Zhu","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.acra.2026.06.010_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejca.2022.09.017","article-title":"Pathological complete response rate and disease-free survival after neoadjuvant chemotherapy in patients with HER2-low and HER2-0 breast cancers","volume":"176","author":"de Nonneville","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.acra.2026.06.010_bib9","article-title":"Adjuvant and neoadjuvant breast cancer treatments: a systematic review of their effects on mortality","volume":"105","author":"Kerr","year":"2022","journal-title":"Cancer Treat\u00a0Rev"},{"key":"10.1016\/j.acra.2026.06.010_bib10","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/j.jacr.2023.02.016","article-title":"ACR appropriateness criteria\u00ae monitoring response to neoadjuvant systemic therapy for breast cancer: 2022 update","volume":"20","author":"Hayward","year":"2023","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.acra.2026.06.010_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.media.2024.103166","article-title":"A survey of label-noise deep learning for medical image analysis","volume":"95","author":"Shi","year":"2024","journal-title":"Med Image Anal"},{"key":"10.1016\/j.acra.2026.06.010_bib12","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1038\/s41598-024-52858-y","article-title":"Transfer learning of pre-treatment quantitative ultrasound multi-parametric images for the prediction of breast cancer response to neoadjuvant chemotherapy","volume":"14","author":"Falou","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.acra.2026.06.010_bib13","first-page":"6175","article-title":"Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome","volume":"11","author":"Park","year":"2020","journal-title":"Nat\u00a0Commun"},{"key":"10.1016\/j.acra.2026.06.010_bib14","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(20)30580-5","article-title":"Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox","volume":"22","author":"Dubsky","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acra.2026.06.010_bib15","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/s41467-020-15027-z","article-title":"Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer","volume":"11","author":"Zheng","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.acra.2026.06.010_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","article-title":"Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Gradishar","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.acra.2026.06.010_bib17","first-page":"290","article-title":"Breast cancer-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Giuliano","year":"2017","journal-title":"CA: a cancer journal for clinicians"},{"key":"10.1016\/j.acra.2026.06.010_bib18","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: american society of clinical oncology\/college of american pathologists clinical practice guideline focused update","volume":"36","author":"Wolff","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acra.2026.06.010_bib19","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/jnci\/djaa201","article-title":"Assessment of Ki67 in breast cancer: updated recommendations from the international Ki67 in breast cancer working group","volume":"113","author":"Nielsen","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.acra.2026.06.010_bib20","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.acra.2026.06.010_bib21","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.5858\/arpa.2012-0290-OA","article-title":"Pathologic response and long-term follow-up in breast cancer patients treated with neoadjuvant chemotherapy: a comparison between classifications and their practical application","volume":"137","author":"Corben","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.acra.2026.06.010_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40644-019-0251-3","article-title":"Are baseline ultrasound and mammographic features associated with rates of pathological completes response in patients receiving neoadjuvant chemotherapy for breast cancer?","volume":"19","author":"Savaridas","year":"2019","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.acra.2026.06.010_bib23","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1148\/radiol.2016152331","article-title":"Pretreatment MR imaging features of triple-negative breast cancer: association with response to neoadjuvant chemotherapy and recurrence-free survival","volume":"281","author":"Bae","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2026.06.010_bib24","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1007\/s00330-021-08461-0","article-title":"Prediction of pathologic complete response on MRI in patients with breast cancer receiving neoadjuvant chemotherapy according to molecular subtypes","volume":"32","author":"Kim","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2026.06.010_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105320","article-title":"Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications","volume":"163","author":"Zeng","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.acra.2026.06.010_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.biopha.2018.06.066","article-title":"Clinical and molecular aspects of breast cancer: Targets and therapies","volume":"106","author":"Godone","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.acra.2026.06.010_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1-Update and clarification: from the RECIST committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.acra.2026.06.010_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/diagnostics12010187","article-title":"A machine learning ensemble based on radiomics to predict BI-RADS category and reduce the biopsy rate of ultrasound-detected suspicious breast masses","volume":"12","author":"Interlenghi","year":"2022","journal-title":"Diagnostics\u00a013"},{"key":"10.1016\/j.acra.2026.06.010_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12957-020-01959-9","article-title":"Direct comparison of magnetic resonance imaging and pathological shrinkage patterns of triple-negative breast cancer after neoadjuvant chemotherapy","volume":"18","author":"Yoshikawa","year":"2020","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.acra.2026.06.010_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1359148","article-title":"Apriori prediction of chemotherapy response in locally advanced breast cancer patients using CT imaging and deep learning: transformer versus transfer learning","volume":"14","author":"Moslemi","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.acra.2026.06.010_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77875-5","article-title":"Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET\/MRI image deep learning","volume":"10","author":"Choi","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.acra.2026.06.010_bib32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/jmri.29405","article-title":"Time-Series MR images identifying complete response to neoadjuvant chemotherapy in breast cancer using a deep learning approach","volume":"61","author":"Liu","year":"2025","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.acra.2026.06.010_bib33","article-title":"Pretreatment DCE-MRI-based deep learning outperforms radiomics analysis in predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer","volume":"12","author":"Peng","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.acra.2026.06.010_bib34","first-page":"835","article-title":"Predicting breast cancer response to neoadjuvant chemotherapy using ensemble deep transfer learning based on CT images","volume":"29","author":"Rezaeijo","year":"2021","journal-title":"J Xray Sci Technol"},{"key":"10.1016\/j.acra.2026.06.010_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101899","article-title":"Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study","volume":"58","author":"Huang","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.acra.2026.06.010_bib36","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1093\/oncolo\/oyad227","article-title":"Deep learning of multimodal ultrasound: stratifying the response to neoadjuvant chemotherapy in breast cancer before treatment","volume":"29","author":"Gu","year":"2024","journal-title":"Oncologist"},{"key":"10.1016\/j.acra.2026.06.010_bib37","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1007\/s00330-023-10238-6","article-title":"Can multi-modal radiomics using pretreatment ultrasound and tomosynthesis predict response to neoadjuvant systemic treatment in breast cancer?","volume":"34","author":"Cai","year":"2024","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.acra.2026.06.010_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13058-022-01580-6","article-title":"An integrated deep learning model for the prediction of pathological complete response to neoadjuvant chemotherapy with serial ultrasonography in breast cancer patients: a multicentre, retrospective study","volume":"24","author":"Wu","year":"2022","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.acra.2026.06.010_bib39","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1007\/s00330-023-09555-7","article-title":"Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer","volume":"33","author":"Yu","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2026.06.010_bib40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejca.2021.01.028","article-title":"Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer","volume":"147","author":"Jiang","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.acra.2026.06.010_bib41","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s00330-023-09967-5","article-title":"Trust and stakeholder perspectives on the implementation of AI tools in clinical radiology","volume":"34","author":"Bergquist","year":"2024","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.acra.2026.06.010_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41746-021-00385-9","article-title":"Do as AI say: susceptibility in deployment of clinical decision-aids","volume":"4","author":"Gaube","year":"2021","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.acra.2026.06.010_bib43","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/a-0637-1601","article-title":"Contrast-enhanced ultrasound for early prediction of response of breast cancer to neoadjuvant chemotherapy","volume":"40","author":"Lee","year":"2019","journal-title":"Ultraschall Med"},{"key":"10.1016\/j.acra.2026.06.010_bib44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/s12885-023-10817-2","article-title":"Development and validation of a radiopathomic model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer patients","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Cancer"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107663322600423X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107663322600423X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:57:21Z","timestamp":1787428641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107663322600423X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S107663322600423X"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2026.06.010","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer using a Longitudinal US-based Stack-model","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2026.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}